Brii Biosciences Limited (HKG:2137)
Hong Kong · Delayed Price · Currency is HKD 1.990
-0.040 (-1.97%)
Aug 22, 2025, 9:45 AM HKT
Brii Biosciences Market Cap
Brii Biosciences has a market cap or net worth of 1.46 billion as of August 21, 2025. Its market cap has increased by 102.07% in one year.
Market Cap
1.46B
Enterprise Value
-876.86M
Revenue
134.48M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.99
Market Cap Chart
Since July 13, 2021, Brii Biosciences's market cap has decreased from 16.21B to 1.46B, a decrease of -90.99%. That is a compound annual growth rate of -44.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2025 | 1.46B | 103.77% |
| Dec 31, 2024 | 716.67M | -56.90% |
| Dec 29, 2023 | 1.66B | -68.96% |
| Dec 30, 2022 | 5.36B | -77.39% |
| Dec 31, 2021 | 23.70B | 46.22% |
| Jul 13, 2021 | 16.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 268.18B |
| Hansoh Pharmaceutical Group Company | 213.81B |
| JD Health International | 212.97B |
| Innovent Biologics | 162.11B |
| Akeso | 154.38B |
| Sino Biopharmaceutical | 133.42B |
| WuXi Biologics | 124.64B |
| CSPC Pharmaceutical Group | 121.65B |